Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is reducing its headcount through 60% as well as agitating its C-suite in order...

Gilead surrenders on $15M MASH bet after mulling preclinical information

.In a year that has observed a confirmation and a boating of readouts for metabolic dysfunction-asso...

Texas biotech axes cancer cells deal, pins really hopes on being overweight

.Alaunos Therapies is axing a contract with Precigen, giving up licensing liberties to an individual...

Capricor allotments more data for DMD therapy after launching BLA

.Capricor Rehabs is taking a triumph tour for their period 2 Duchenne muscle dystrophy (DMD) trial. ...

FDA spots Kezar lupus trial in grip following 4 person deaths

.The FDA has put Kezar Life Sciences' lupus test on grip after the biotech hailed 4 deaths throughou...

Phase 3 Scholar Stone trial reaches SMA objective, sending out stockpile 200%

.A stage 3 test of Intellectual Stone's back muscle atrophy (SMA) applicant has actually struck its ...

CAMP 4 is most current to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Rehabs has defined prepare for a $67 million IPO, with inflammation-focused Upstr...

Galecto purchases leukemia drug, drops bone cancer cells resource in pivot

.A year after the failing of an idiopathic lung fibrosis candidate sent out Galecto on a look for re...

Judo throws down $100M to knock out renal condition

.Taking the floor covering is actually Judo Biography, an ambitious biotech armed with $100 million ...

AstraZeneca spends CSPC $100M for preclinical heart problem drug

.AstraZeneca has paid CSPC Drug Group $one hundred thousand for a preclinical cardiovascular disease...